FI114705B - Kinolonijohdannainen virtsainkontinenssin hoitoon - Google Patents

Kinolonijohdannainen virtsainkontinenssin hoitoon Download PDF

Info

Publication number: FI114705B
Authority: FI; Finland
Prior art keywords: compound; cyanophenyl; trifluoromethyl; att; formula
Prior art date: 1994-04-14

Application number

FI964019A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI964019A0 (fi

FI964019A (fi

Inventor

Diane Amy Trainor

James Michael Hulsizer

Jr Cyrus John Ohnmacht

John Edward Warawa

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-14

Filing date

1996-10-07

Publication date

2004-12-15

1996-10-07 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

1996-10-07 Publication of FI964019A0 publication Critical patent/FI964019A0/fi

1996-10-07 Publication of FI964019A publication Critical patent/FI964019A/fi

2004-12-15 Application granted granted Critical

2004-12-15 Publication of FI114705B publication Critical patent/FI114705B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FI964019A 1994-04-14 1996-10-07 Kinolonijohdannainen virtsainkontinenssin hoitoon FI114705B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9407432A GB9407432D0 (en)	1994-04-14	1994-04-14	Heterocyclic derivative
GB9407432		1994-04-14
PCT/GB1995/000845 WO1995028388A1 (en)	1994-04-14	1995-04-13	Quinolone derivative for treatment of urinary incontinence
GB9500845		1995-04-13

Publications (3)

Publication Number	Publication Date
FI964019A0 FI964019A0 (fi)	1996-10-07
FI964019A FI964019A (fi)	1996-10-07
FI114705B true FI114705B (fi)	2004-12-15

Family

ID=10753541

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FI964019A FI114705B (fi)	1994-04-14	1996-10-07	Kinolonijohdannainen virtsainkontinenssin hoitoon
FI20040352A FI115630B (fi)	1994-04-14	2004-03-04	Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FI20040352A FI115630B (fi)	1994-04-14	2004-03-04	Menetelmä 4-(3-syaanifenyyli)-trifluorimetyyli-5-okso-1,4,5,6,7,8-heksahydrokinoliini-3-karboksyylihapon valmistamiseksi

Country Status (25)

Country	Link
EP (1)	EP0755382B1 (cs)
JP (1)	JP3782445B2 (cs)
KR (1)	KR100344885B1 (cs)
CN (1)	CN1058708C (cs)
AT (1)	ATE202089T1 (cs)
AU (1)	AU700773B2 (cs)
BR (1)	BR9507366A (cs)
CA (1)	CA2187525C (cs)
CZ (1)	CZ284652B6 (cs)
DE (1)	DE69521310T2 (cs)
DK (1)	DK0755382T3 (cs)
ES (1)	ES2159633T3 (cs)
FI (2)	FI114705B (cs)
GB (1)	GB9407432D0 (cs)
GR (1)	GR3036482T3 (cs)
HK (1)	HK1013999A1 (cs)
HU (1)	HU215387B (cs)
MX (1)	MX9603920A (cs)
NO (1)	NO307177B1 (cs)
NZ (1)	NZ283779A (cs)
PL (2)	PL182031B1 (cs)
PT (1)	PT755382E (cs)
RU (1)	RU2149870C1 (cs)
SK (1)	SK281124B6 (cs)
WO (1)	WO1995028388A1 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE373642T1 (de) *	1999-08-03	2007-10-15	Abbott Lab	Kalium kanalaktivatoren
WO2002010134A1 (en) *	2000-08-02	2002-02-07	Astrazeneca Ab	Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv)	2002-01-24	2002-01-24	Astrazeneca Ab	Method
CN102532015B (zh) *	2012-01-18	2013-10-23	云南大学	香豆素及其类似物的固相合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2003148A1 (de) *	1970-01-24	1971-07-29	Bayer Ag	Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) *	1991-10-21	1992-11-11	Ici Plc	Therapeutic agent
GB9318935D0 (en) *	1992-10-20	1993-10-27	Zeneca Ltd	Heterocyclic derivatives

1994
- 1994-04-14 GB GB9407432A patent/GB9407432D0/en active Pending
1995
- 1995-04-13 CN CN95192577A patent/CN1058708C/zh not_active Expired - Fee Related
- 1995-04-13 WO PCT/GB1995/000845 patent/WO1995028388A1/en active IP Right Grant
- 1995-04-13 SK SK1317-96A patent/SK281124B6/sk not_active IP Right Cessation
- 1995-04-13 NZ NZ283779A patent/NZ283779A/en not_active IP Right Cessation
- 1995-04-13 AT AT95915256T patent/ATE202089T1/de not_active IP Right Cessation
- 1995-04-13 PL PL95316790A patent/PL182031B1/pl not_active IP Right Cessation
- 1995-04-13 JP JP52680695A patent/JP3782445B2/ja not_active Expired - Fee Related
- 1995-04-13 DE DE69521310T patent/DE69521310T2/de not_active Expired - Fee Related
- 1995-04-13 ES ES95915256T patent/ES2159633T3/es not_active Expired - Lifetime
- 1995-04-13 KR KR1019960705672A patent/KR100344885B1/ko not_active IP Right Cessation
- 1995-04-13 PT PT95915256T patent/PT755382E/pt unknown
- 1995-04-13 HU HU9602747A patent/HU215387B/hu not_active IP Right Cessation
- 1995-04-13 EP EP95915256A patent/EP0755382B1/en not_active Expired - Lifetime
- 1995-04-13 DK DK95915256T patent/DK0755382T3/da active
- 1995-04-13 CA CA002187525A patent/CA2187525C/en not_active Expired - Fee Related
- 1995-04-13 BR BR9507366A patent/BR9507366A/pt not_active IP Right Cessation
- 1995-04-13 MX MX9603920A patent/MX9603920A/es not_active IP Right Cessation
- 1995-04-13 PL PL95343448A patent/PL183095B1/pl not_active IP Right Cessation
- 1995-04-13 CZ CZ962981A patent/CZ284652B6/cs not_active IP Right Cessation
- 1995-04-13 RU RU96119966/04A patent/RU2149870C1/ru active
- 1995-04-13 AU AU22199/95A patent/AU700773B2/en not_active Ceased
1996
- 1996-10-07 FI FI964019A patent/FI114705B/fi active
- 1996-10-11 NO NO964345A patent/NO307177B1/no not_active IP Right Cessation
1998
- 1998-12-24 HK HK98115420A patent/HK1013999A1/xx not_active IP Right Cessation
2001
- 2001-08-31 GR GR20010401341T patent/GR3036482T3/el not_active IP Right Cessation
2004
- 2004-03-04 FI FI20040352A patent/FI115630B/fi active IP Right Grant

Also Published As

Publication number	Publication date
CZ284652B6 (cs)	1999-01-13
CA2187525A1 (en)	1995-10-26
SK281124B6 (sk)	2000-12-11
FI20040352A (fi)	2004-03-04
HUT76132A (en)	1997-06-30
PT755382E (pt)	2001-11-30
GB9407432D0 (en)	1994-06-08
DE69521310D1 (de)	2001-07-19
NO307177B1 (no)	2000-02-21
PL182031B1 (pl)	2001-10-31
NO964345L (no)	1996-12-11
WO1995028388A1 (en)	1995-10-26
CN1146202A (zh)	1997-03-26
DK0755382T3 (da)	2001-09-10
CZ298196A3 (en)	1997-02-12
FI964019A0 (fi)	1996-10-07
JPH09512254A (ja)	1997-12-09
AU2219995A (en)	1995-11-10
CN1058708C (zh)	2000-11-22
BR9507366A (pt)	1997-09-23
ATE202089T1 (de)	2001-06-15
PL183095B1 (pl)	2002-05-31
PL316790A1 (en)	1997-02-17
GR3036482T3 (en)	2001-11-30
HU9602747D0 (en)	1996-11-28
HK1013999A1 (en)	1999-09-17
AU700773B2 (en)	1999-01-14
RU2149870C1 (ru)	2000-05-27
FI115630B (fi)	2005-06-15
KR100344885B1 (ko)	2002-11-30
SK131796A3 (en)	1997-05-07
CA2187525C (en)	2006-01-24
NZ283779A (en)	1998-02-26
ES2159633T3 (es)	2001-10-16
NO964345D0 (no)	1996-10-11
EP0755382A1 (en)	1997-01-29
DE69521310T2 (de)	2002-04-18
JP3782445B2 (ja)	2006-06-07
EP0755382B1 (en)	2001-06-13
MX9603920A (es)	1997-04-30
HU215387B (hu)	1998-12-28
FI964019A (fi)	1996-10-07

Publication	Publication Date	Title
AU654148B2 (en)	1994-10-27	R(+)-terazosin
RU2659784C2 (ru)	2018-07-04	Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
FI110940B (fi)	2003-04-30	Menetelmä terapeuttisesti aktiivisten kinoloni- ja akridonijohdannaisten valmistamiseksi
US5484792A (en)	1996-01-16	1,8-(2H,5H)-acridinedione therapeutic agents
FI90545C (fi)	1994-02-25	Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
EP0024960B1 (fr)	1984-12-12	Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
FI114705B (fi)	2004-12-15	Kinolonijohdannainen virtsainkontinenssin hoitoon
US5455253A (en)	1995-10-03	Heterocyclic derivatives
JPH04178356A (ja)	1992-06-25	光学活性なベンジルアルコール誘導体及びその用途
AU731407B2 (en)	2001-03-29	Quinolone derivative for treatment of urinary incontinence
CN110066310A (zh)	2019-07-30	丹参酮iia噻吩吡啶类化合物及其制备方法和用途
JPH0656833A (ja)	1994-03-01	血液循環の中断による神経損傷を治療するためのキサンチン誘導体の使用
JPH04368387A (ja)	1992-12-21	多環式ニトリル化合物およびその医薬組成物